DAZATRO Trademark

Trademark Overview

On Wednesday, December 10, 2014, a trademark application was filed for DAZATRO with the United States Patent and Trademark Office. The USPTO has given the DAZATRO trademark a serial number of 86476339. The federal status of this trademark filing is REGISTERED as of Tuesday, November 6, 2018. This trademark is owned by Glaxo Group Limited. The DAZATRO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
dazatro

General Information

Serial Number86476339
Word MarkDAZATRO
Filing DateWednesday, December 10, 2014
Status700 - REGISTERED
Status DateTuesday, November 6, 2018
Registration Number5598254
Registration DateTuesday, November 6, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 21, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 15, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Monday, November 6, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, October 28, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, October 28, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 28, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 28, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, October 28, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, December 9, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, December 9, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 6, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, August 21, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 21, 2018PUBLISHED FOR OPPOSITION
Wednesday, August 1, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, July 16, 20181(B) BASIS DELETED; NEW BASIS REQUESTED
Monday, July 16, 2018NOTICE OF ALLOWANCE CANCELLED
Friday, July 13, 2018PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Tuesday, July 10, 2018ASSIGNED TO PETITION STAFF
Friday, June 15, 2018TEAS PETITION TO AMEND BASIS RECEIVED
Tuesday, November 21, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, November 18, 2017SOU EXTENSION 5 GRANTED
Tuesday, November 14, 2017SOU EXTENSION 5 FILED
Tuesday, November 14, 2017SOU TEAS EXTENSION RECEIVED
Thursday, July 13, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 11, 2017SOU EXTENSION 4 GRANTED
Tuesday, July 11, 2017SOU EXTENSION 4 FILED
Tuesday, July 11, 2017SOU TEAS EXTENSION RECEIVED
Tuesday, December 20, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, December 18, 2016SOU EXTENSION 3 GRANTED
Tuesday, December 6, 2016SOU EXTENSION 3 FILED
Tuesday, December 6, 2016SOU TEAS EXTENSION RECEIVED
Saturday, August 6, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 5, 2016SOU EXTENSION 2 GRANTED
Wednesday, June 29, 2016SOU EXTENSION 2 FILED
Friday, July 29, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, June 29, 2016SOU TEAS EXTENSION RECEIVED
Wednesday, December 23, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 21, 2015SOU EXTENSION 1 GRANTED
Monday, December 21, 2015SOU EXTENSION 1 FILED
Monday, December 21, 2015SOU TEAS EXTENSION RECEIVED
Tuesday, July 14, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 19, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 19, 2015PUBLISHED FOR OPPOSITION
Wednesday, April 29, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, April 10, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, April 10, 2015ASSIGNED TO LIE
Thursday, March 19, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 18, 2015ASSIGNED TO EXAMINER
Monday, December 15, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, December 13, 2014NEW APPLICATION ENTERED

Related Keywords

dazatro pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological